Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

Protracted venous infusion 5-fluorouracil (5FU) combined with mitomycin C (MMC) has demonstrated significant activity against metastatic colorectal cancer. Owing to potential synergy based upon upregulation of thymidine phosphorylase by MMC, the combination of capecitabine and MMC may improve outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, G, Dickson, J L B, Cunningham, D, Norman, A R, Rao, S, Hill, M E, Price, T J, Oates, J, Tebbutt, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361607/
https://www.ncbi.nlm.nih.gov/pubmed/16091760
http://dx.doi.org/10.1038/sj.bjc.6602733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361607/
https://www.ncbi.nlm.nih.gov/pubmed/16091760
http://dx.doi.org/10.1038/sj.bjc.6602733

Ejemplares similares